Rafoxanide
Therapeutic Category:
Anthelmintic
Uncouples oxidative phosphorylation in parasite mitochondria, disrupting ATP synthesis and leading to parasite death
Primary Use:
Treatment of fascioliasis and other fluke infestations, especially Fasciola hepatica and F. giganticaSystemic control of fleas and ticks in dogs.
Active against liver flukes, some roundworms, and certain blood-sucking nematodes
Target Species:
Cattle, sheep, goats
Status:
Commercial
Monograph:
In House
Regulatory Status:
DMF
Disclaimer*
NGL FINE CHEM LIMITED is committed to protect the intellectual property (IP) generated in house and equally committed to respect the IP rights of all entities. Certain pipeline products may have valid patent(s) by other in India and/or in other jurisdictions. NGL offers such patented products for research and testing purpose only. The buyer will have the exclusive responsibility to respect the third party patent rights whether related to product or process.